New CFTR MASTR Dx validated for dried blood spots

New CFTR MASTR Dx validated for dried blood spots

Anatomy - Pathology / Molecular Diagnostics

March 12, 2015

Multiplicom is pleased to announce that CFTR MASTR™ Dx has been successfully validated for an additional sample type: dried blood spots. The CE-IVD claim is now extended to include DNA extracted from dried blood spots, allowing you to use the assay for routine neonatal screening.

The CFTR MASTR™ Dx is a molecular diagnostic assay for identification of sequence variants covering the complete CFTR gene in individuals with increased risk for CF, in CF-carriers or CF-related phenotypes.

Multiplicom’s CFTR MASTR™ Dx assay is provided as a ready-to-use kit that offers robust performance with minimum hands-on time. All reagents necessary to enable multiplex amplification of 48 amplicons (300-450 bp) in two PCR reactions are included, targeting all coding exons, selected intronic regions and part of the promoter region. The assay is validated for DNA derived from whole blood, as well as from dried blood spots.

The assay is compatible with all current Massively Parallel Sequencing (MPS) systems, providing the flexibility to choose your preferred method.

Cubis®High-Capacity Micro Balances: Weigh Minimum Amounts of Sample Directly into Heavy Flasks

Cubis®High-Capacity Micro Balances: Weigh Minimum Amounts of Sample Directly into Heavy Flasks

Anatomy - Pathology / Molecular Diagnostics

With a unique resolution of up to 60 million divisions and a readability of 1 μg, the new high-capacity Cubis® MSA66S micro-analytical balances feature a maximum capacity of 61 g.
Based on this high weighing capacity, you will no longer need to transfer samples and can weigh minimum amounts directly into relatively heavy containers, such as long-necked flasks or HPLC bottles, saving an extra step in your procedure, ensuring that you can use 100% of your sample.

 

 

January 17, 2018 More +
Innovative NGS technology for gene expression profiling

Innovative NGS technology for gene expression profiling

Anatomy - Pathology / Molecular Diagnostics

We’ve got 6 reasons for you to move beyond qPCR for gene expression profiling! QIAGEN’s QIAseq Targeted RNA Panels offer you a simple and complete Sample to Insight solution for pathway- or disease-focused gene expression profiling with unmatched accuracy, sensitivity, specificity, reproducibility and high throughput.

January 09, 2017 More +
Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us